Netflix’s Earnings Rebound, Surveying the Airline Stocks, and BioMarin CEO 10/19/22
Mad Money w/ Jim Cramer
00:00
Rotavian: A Transformative Therapy for Hemophilia
We hope to be treating our first commercial patient in uh in germany at the end of this month. The FDA did accept our filing in the u.s. last week so we have a chance to be approved next year. This is transformative therapy and i've talked to a few hemophilia patients that i've taken rotavian and it has absolutely changed their lives.
Transcript
Play full episode
